Market Place
Sourcing Support
JB Pharma posts Q2 FY25 PAT 16% higher at Rs. 175 Cr
07 Nov 2024 //
INDPHARMAPOST
India`s JB Pharma`s Q2 profit rises on higher domestic demand
06 Nov 2024 //
REUTERS
JB Pharma Launches 3rd Sustainability Report With ESG Commitments
23 Oct 2024 //
EXPRESSPHARMA
JB Pharma records 12 per cent revenue growth in Q1
09 Aug 2024 //
ECONOMICTIMES
JB Pharma expects India business to grow above market growth rate in FY25
21 May 2024 //
ECONOMICTIMES
JB Pharma acquires distribution rights of Novartis eye care portfolio in India
20 Dec 2023 //
ECONOMIC TIMES
JB Pharma open to more buys to grow branded biz share
24 Nov 2023 //
ECONOMIC TIMES
JB Pharma launches knowledge based app for doctors
29 Jun 2023 //
EXPRESS PHARMA
JB Pharma completes 1 year of its identity launch
06 Jun 2023 //
INDIAN PHARMA POST
JB Pharma records revenue growth of 22% to Rs. 762 Cr
25 May 2023 //
INDIAN PHARMA POST
JB Pharma records revenue growth of 32% to Rs. 793 Cr in Q3 FY23
09 Feb 2023 //
INDIAN PHARMA POST
JB Pharma acquires cardiac brand from Glenmark for Rs 314 crore
15 Dec 2022 //
ECONOMIC TIMES
JB Pharma cuts price of its top-selling heart failure drug Azmarda by 50%
06 Dec 2022 //
ECONOMICTIMES
JB Pharma records revenue growth of 36% to INR 809 crores in Q2 FY23
12 Nov 2022 //
HEALTH ET
JB Pharma rolls out campaign to spread awareness about heart health
23 Sep 2022 //
PHARMABIZ
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.